Low-dose alemtuzumab induction in a tailored immunosuppression protocol for sensitized kidney transplant recipients

Induction therapy is crucial in kidney transplantation and constitutes an important cornerstone for long-term allograft survival. Alemtuzumab is a depleting CD52-specific antibody with T- and B-cell activity, ...

Source: BMC Nephrology - May 13, 2020 Category: Urology & Nephrology Authors: Martina Guthoff, Kilian Berger, Karina Althaus, Thomas M ühlbacher, Tamam Bakchoul, Wolfgang Steurer, Silvio Nadalin, Alfred Königsrainer and Nils Heyne Tags: Research article Source Type: research